1. Home
  2. RAYA vs VIVS Comparison

RAYA vs VIVS Comparison

Compare RAYA & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$2.28

Market Cap

3.1M

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$0.33

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAYA
VIVS
Founded
2019
2007
Country
China
United States
Employees
N/A
9
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
RAYA
VIVS
Price
$2.28
$0.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.6K
4.8M
Earning Date
04-17-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.95
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.31
52 Week High
$10.14
$5.30

Technical Indicators

Market Signals
Indicator
RAYA
VIVS
Relative Strength Index (RSI) 41.55 19.62
Support Level $0.75 N/A
Resistance Level $2.95 $1.62
Average True Range (ATR) 0.18 0.12
MACD -0.03 -0.01
Stochastic Oscillator 34.52 2.35

Price Performance

Historical Comparison
RAYA
VIVS

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc is engaged in the manufacturing, research and development (R&D), and wholesale and retail of power solution products. The group focuses on manufacturing new energy storage and inverter devices. Its product portfolio includes sine wave and off-grid inverters, inverters and gasoline generators, battery and smart chargers, and custom-designed products. The products are used principally in agricultural and industrial vehicles, recreational vehicles (RVs), electrical appliances, and outdoor living products. The company generates the majority of its revenue from Inverters. The company generates revenue from five main markets, which are China, Poland, Mexico, the U.K., and Portugal. It derives maximum revenue from China.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: